| Net loss | -895.42K |
| Depreciation and amortization | 1.24M |
| Provision for doubtful accounts | 1.96K |
| Deferred income taxes | -13.11K |
| Amortization of deferred financing fees | |
| Non-cash interest charge | |
| Recognition of rent incentive benefit | -23.5K |
| Stock option grant expense | |
| Loss on disposal of property and equipment | |
| Trade receivables | 575.78K |
| Note and settlement receivables | |
| Prepaid expenses | -29.66K |
| Income taxes | -175.3K |
| Other assets | 189.2K |
| Accounts payable | 18.27K |
| Accrued expenses | -451.74K |
| Accrued wages and other compensation | -13K |
| Deferred revenue | -1.99M |
| Cash provided by operating activities | |
| Additions to property, equipment, and software | -930.53K |
| Cash used in investing activities | |
| Borrowings under credit agreements | |
| Repayments under credit agreements | |
| Advance from shareholder | |
| Repayment of advance from shareholder | |
| Cash (used in) / provided by financing activities | |
| Effect of foreign currency exchange rates on cash and cash equivalents | -115.53K |
| Increase / (decrease) in cash and cash equivalents | -2.36M |
| Cash and cash equivalents, beginning of period | 5.28M |
| Cash and cash equivalents, end of period | 2.91M |